UK Biotech Day is one of the leading events for the biotech and life sciences sector in Europe. On May 27–28, 2026, London will host hundreds of professionals, Data Managers, CRAs, and Clinical Operations Managers looking for technological solutions to optimize clinical trial management. Participating means stepping into the heart of innovation applied to clinical research.
Nubilaria will be attending to bring the ACTide ecosystem to Europe’s leading biotech hub, showcasing tools designed to optimize data management, study timelines, and regulatory compliance throughout the entire clinical trial life cycle.
UK Biotech Day 2026: innovation for clinical research
The event represents a strategic meeting point between technological innovation and clinical research. It allows industry professionals to explore new digital solutions for trial management, with a strong focus on operational efficiency, data quality, and the digital transformation of multicenter studies.
The focus on innovation in clinical research and process digitalization, networking among sponsors, CROs, and European technology providers, discussions on regulatory standards such as ICH-GCP and data integrity, and the exploration of solutions to reduce time-to-study and operational costs are all aspects that make UK Biotech Day an unmissable event.
During UK Biotech Day 2026, discover how the ACTide ecosystem can support your clinical studies.
Book a meeting with our experts to see a live demo and evaluate how to improve efficiency, data quality, and startup timelines for your clinical trials.
The Nubilaria team you will meet in London
Our team will be represented by Erich Cavicchiolo and Giulia Tacchino, key figures in the development and implementation of the ACTide ecosystem. Their focus will be helping sponsors and CROs assess how to improve efficiency, data quality, and time-to-study through advanced digital solutions.
What you can discuss with our experts
- strategies to optimize clinical project costs and timelines using scalable technology.
- How ACTide eCRF reduces data entry time and improves the quality of collected data.
- Data Manager autonomy with ACTide Designer to create and modify eCRFs without depending on IT teams.
- Patient-centricity with ACTide ePRO: collecting patient-reported data in a structured and compliant way.
Want to learn more before the event?
Visit the ACTide website to discover all the modules of the ecosystem.
Nubilaria at UK Biotech Day
Nubilaria’s stand at UK Biotech Day 2026 is designed to demonstrate in practical terms how ACTide transforms the workflow of Data Managers and CRAs. It is not just a technology showcase, but also a meeting point where you can discuss your real projects and understand how AI integration and rapid setup can make a difference in your clinical studies.
What you gain by visiting our stand
- consultation for your clinical project.
- Live demo of ACTide.
- Direct discussion with experts who understand the daily challenges faced by Clinical Operations teams.
- Straight answers to your compliance questions.
Discover how ACTide can optimize your next trial. Visit Nubilaria’s stand during UK Biotech Day: live demos, free consultation, and no obligation.
We look forward to seeing you in London: discover the future of clinical research
UK Biotech Day 2026 is the perfect opportunity to see firsthand how technology can concretely transform the work of Data Managers, CRAs, and Clinical Operations Managers.
The Nubilaria team looks forward to meeting you in London on May 27–28. Come and discover how ACTide is redefining the standards of digital clinical trial management across Europe and worldwide.
How to find and contact us:
- event: May 27–28, 2026, London, Orbite Conference Centre, Radisson Hotel & Conference Centre – Building A, Bath Road, Heathrow Boulevard, Sipson UB7 0DU.
- Stand: Nubilaria
- Contacts: Erich Cavicchiolo and Giulia Tacchino.
Clinical research is evolving rapidly. Adopting integrated digital tools means reducing inefficiencies, accelerating trials, and improving data quality.
Meeting Nubilaria in London is the first step toward turning these goals into operational reality.